Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 48.7
(-4.58%)
CNY 48.7
(-4.58%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -20.67 Billion CNY | -50.32% |
| 2022 | -13.75 Billion CNY | -2.02% |
| 2021 | -13.47 Billion CNY | -46.46% |
| 2020 | -9.2 Billion CNY | -99.04% |
| 2019 | -4.62 Billion CNY | -42.94% |
| 2018 | -3.23 Billion CNY | 13.48% |
| 2017 | -3.73 Billion CNY | 23.21% |
| 2016 | -4.86 Billion CNY | 4.97% |
| 2015 | -5.12 Billion CNY | -48.97% |
| 2014 | -3.43 Billion CNY | -60.02% |
| 2013 | -2.14 Billion CNY | -62.88% |
| 2012 | -1.31 Billion CNY | -41.97% |
| 2011 | -929.38 Million CNY | 4.68% |
| 2010 | -975.04 Million CNY | -39.84% |
| 2009 | -697.24 Million CNY | -81.02% |
| 2008 | -385.18 Million CNY | 24.84% |
| 2007 | -512.49 Million CNY | 0.98% |
| 2006 | -517.55 Million CNY | -34.98% |
| 2005 | -383.43 Million CNY | -44.98% |
| 2004 | -264.47 Million CNY | -205.12% |
| 2003 | 251.58 Million CNY | 82.82% |
| 2002 | 137.61 Million CNY | 33.06% |
| 2001 | 103.42 Million CNY | 158.37% |
| 2000 | -177.17 Million CNY | -290.74% |
| 1999 | 92.89 Million CNY | -6.08% |
| 1998 | 98.9 Million CNY | 10.62% |
| 1997 | 89.41 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -21.22 Billion CNY | -2.69% |
| 2024 Q2 | -21.82 Billion CNY | -2.81% |
| 2024 Q3 | -22.09 Billion CNY | -1.17% |
| 2023 Q4 | -20.67 Billion CNY | -19.37% |
| 2023 Q1 | -14.13 Billion CNY | -2.83% |
| 2023 Q2 | -16.05 Billion CNY | -13.52% |
| 2023 FY | -20.67 Billion CNY | -50.32% |
| 2023 Q3 | -17.31 Billion CNY | -7.88% |
| 2022 Q1 | -13.46 Billion CNY | 0.13% |
| 2022 Q3 | -15.85 Billion CNY | -19.29% |
| 2022 FY | -13.75 Billion CNY | -2.02% |
| 2022 Q4 | -13.75 Billion CNY | 13.26% |
| 2022 Q2 | -13.28 Billion CNY | 1.29% |
| 2021 Q3 | -14.28 Billion CNY | -14.66% |
| 2021 Q4 | -13.47 Billion CNY | 5.63% |
| 2021 Q1 | -12.52 Billion CNY | -15.91% |
| 2021 FY | -13.47 Billion CNY | -46.46% |
| 2021 Q2 | -12.45 Billion CNY | 0.53% |
| 2020 Q2 | -9.56 Billion CNY | -9.05% |
| 2020 Q1 | -8.76 Billion CNY | -73.87% |
| 2020 Q3 | -11.05 Billion CNY | -15.56% |
| 2020 Q4 | -10.8 Billion CNY | 2.23% |
| 2020 FY | -9.2 Billion CNY | -99.04% |
| 2019 Q3 | -3.95 Billion CNY | 9.01% |
| 2019 Q2 | -4.34 Billion CNY | -1.92% |
| 2019 FY | -4.62 Billion CNY | -42.94% |
| 2019 Q1 | -4.26 Billion CNY | -9.69% |
| 2019 Q4 | -5.04 Billion CNY | -27.48% |
| 2018 Q1 | -4.42 Billion CNY | -3.58% |
| 2018 Q2 | -3.52 Billion CNY | 20.22% |
| 2018 Q3 | -4.56 Billion CNY | -29.35% |
| 2018 FY | -3.23 Billion CNY | 13.48% |
| 2018 Q4 | -3.88 Billion CNY | 14.73% |
| 2017 Q1 | -5.96 Billion CNY | -21.42% |
| 2017 FY | -3.73 Billion CNY | 23.21% |
| 2017 Q4 | -4.26 Billion CNY | -19.12% |
| 2017 Q3 | -3.58 Billion CNY | 23.86% |
| 2017 Q2 | -4.7 Billion CNY | 21.12% |
| 2016 Q2 | -5.78 Billion CNY | -5.22% |
| 2016 FY | -4.86 Billion CNY | 4.97% |
| 2016 Q3 | -6.19 Billion CNY | -7.1% |
| 2016 Q1 | -5.49 Billion CNY | -7.27% |
| 2016 Q4 | -4.91 Billion CNY | 20.68% |
| 2015 FY | -5.12 Billion CNY | -48.97% |
| 2015 Q4 | -5.12 Billion CNY | -10.66% |
| 2015 Q1 | -3.81 Billion CNY | -11.05% |
| 2015 Q2 | -4.13 Billion CNY | -8.22% |
| 2015 Q3 | -4.62 Billion CNY | -12.01% |
| 2014 Q1 | -2.34 Billion CNY | -9.26% |
| 2014 Q3 | -3.07 Billion CNY | -10.07% |
| 2014 Q2 | -2.79 Billion CNY | -19.13% |
| 2014 Q4 | -3.43 Billion CNY | -11.69% |
| 2014 FY | -3.43 Billion CNY | -60.02% |
| 2013 Q1 | -1.58 Billion CNY | -20.38% |
| 2013 Q2 | -1.66 Billion CNY | -4.86% |
| 2013 Q3 | -1.79 Billion CNY | -7.9% |
| 2013 Q4 | -2.14 Billion CNY | -19.59% |
| 2013 FY | -2.14 Billion CNY | -62.88% |
| 2012 Q2 | -1.05 Billion CNY | -11.7% |
| 2012 Q1 | -942.39 Million CNY | -1.4% |
| 2012 Q4 | -1.31 Billion CNY | -6.74% |
| 2012 FY | -1.31 Billion CNY | -41.97% |
| 2012 Q3 | -1.23 Billion CNY | -17.44% |
| 2011 FY | -929.38 Million CNY | 4.68% |
| 2011 Q4 | -929.38 Million CNY | 1.11% |
| 2011 Q3 | -939.83 Million CNY | 1.47% |
| 2011 Q2 | -953.88 Million CNY | -2.3% |
| 2011 Q1 | -932.4 Million CNY | 4.37% |
| 2010 Q2 | -753.18 Million CNY | -1.53% |
| 2010 Q4 | -975.04 Million CNY | -6.84% |
| 2010 FY | -975.04 Million CNY | -39.84% |
| 2010 Q3 | -912.61 Million CNY | -21.17% |
| 2010 Q1 | -741.8 Million CNY | -6.39% |
| 2009 FY | -697.24 Million CNY | -81.02% |
| 2009 Q3 | -671.99 Million CNY | 11.51% |
| 2009 Q1 | -667.73 Million CNY | -73.36% |
| 2009 Q2 | -759.41 Million CNY | -13.73% |
| 2009 Q4 | -697.24 Million CNY | -3.76% |
| 2008 Q3 | -433.55 Million CNY | 18.0% |
| 2008 FY | -385.18 Million CNY | 24.84% |
| 2008 Q1 | -551.12 Million CNY | -7.54% |
| 2008 Q2 | -528.7 Million CNY | 4.07% |
| 2008 Q4 | -385.18 Million CNY | 11.16% |
| 2007 Q4 | -512.49 Million CNY | 30.07% |
| 2007 Q3 | -732.82 Million CNY | -11.92% |
| 2007 Q2 | -654.75 Million CNY | -4.66% |
| 2007 Q1 | -625.61 Million CNY | -20.88% |
| 2007 FY | -512.49 Million CNY | 0.98% |
| 2006 Q1 | -414.99 Million CNY | -8.23% |
| 2006 Q2 | -465.66 Million CNY | -12.21% |
| 2006 Q3 | -507.14 Million CNY | -8.91% |
| 2006 FY | -517.55 Million CNY | -34.98% |
| 2006 Q4 | -517.55 Million CNY | -2.05% |
| 2005 Q1 | -271.7 Million CNY | -2.73% |
| 2005 FY | -383.43 Million CNY | -44.98% |
| 2005 Q2 | -333.97 Million CNY | -22.92% |
| 2005 Q3 | -366.64 Million CNY | -9.78% |
| 2005 Q4 | -383.43 Million CNY | -4.58% |
| 2004 Q1 | 169.27 Million CNY | -32.72% |
| 2004 Q3 | -195.7 Million CNY | -402.83% |
| 2004 Q4 | -264.47 Million CNY | -35.14% |
| 2004 Q2 | -38.92 Million CNY | -122.99% |
| 2004 FY | -264.47 Million CNY | -205.12% |
| 2003 Q4 | 251.58 Million CNY | -4.24% |
| 2003 Q1 | 202.4 Million CNY | 47.08% |
| 2003 Q3 | 262.71 Million CNY | 3.91% |
| 2003 Q2 | 252.83 Million CNY | 24.92% |
| 2003 FY | 251.58 Million CNY | 82.82% |
| 2002 Q2 | 124.68 Million CNY | 130.74% |
| 2002 Q1 | 54.03 Million CNY | -47.75% |
| 2002 FY | 137.61 Million CNY | 33.06% |
| 2002 Q4 | 137.61 Million CNY | 34.79% |
| 2002 Q3 | 102.09 Million CNY | -18.11% |
| 2001 FY | 103.42 Million CNY | 158.37% |
| 2001 Q2 | -64.92 Million CNY | 0.0% |
| 2001 Q4 | 103.42 Million CNY | 0.0% |
| 2000 Q4 | -177.17 Million CNY | 0.0% |
| 2000 FY | -177.17 Million CNY | -290.74% |
| 1999 FY | 92.89 Million CNY | -6.08% |
| 1998 FY | 98.9 Million CNY | 10.62% |
| 1997 FY | 89.41 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 248.15 Million CNY | 8429.978% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | -1.53 Billion CNY | -1247.594% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | -309.42 Million CNY | -6580.4% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | -8129.83% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 16.8 Million CNY | 123113.131% |
| NanJing Pharmaceutical Company Limited | 9.24 Billion CNY | 323.592% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 32.59 Million CNY | 63514.794% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | -954.2 Million CNY | -2066.3% |